Patient acceptability of intravitreal complement inhibitors in geographic atrophy (GA): protocol for a UK-based cross-sectional study.
Christiana DinahJamie EnochArevik GhulakhszianMandeep SekhonDavid P CrabbDeanna J TaylorPublished in: BMJ open (2024)
The study received ethical approval from the Health Research Authority on 14 March 2023 (IRAS Project ID: 324854). Findings will be disseminated through peer-reviewed publications and conference presentations to the medical retina community, as well as through dialogue with patients and macular disease charities.
Keyphrases
- diabetic retinopathy
- end stage renal disease
- healthcare
- ejection fraction
- chronic kidney disease
- newly diagnosed
- peritoneal dialysis
- randomized controlled trial
- optical coherence tomography
- pet ct
- mental health
- age related macular degeneration
- prognostic factors
- case report
- quality improvement
- vascular endothelial growth factor
- patient reported outcomes
- endothelial cells
- decision making